Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of pioglitazone on osteoprotegerin in type 2 diabetes
2006-007027-14Phase 4Terminated
- Sponsor
- Inserm
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Inserm. Primary endpoints: Change in plasma osteoprotegerin, Kinetics of osteoprotegerin change and 8 more. Started Apr 2007; status: terminated.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-007027-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-007027-14.